Cargando…
Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease
Autores principales: | Lodé, L, Moreau, P, Ménard, A, Godon, C, Touzeau, C, Amiot, M, Le Gouill, S, Béné, M C, Pellat-Deceunynck, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880443/ https://www.ncbi.nlm.nih.gov/pubmed/24270325 http://dx.doi.org/10.1038/bcj.2013.60 |
Ejemplares similares
-
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
por: Touzeau, C, et al.
Publicado: (2014) -
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma
por: Maïga, S, et al.
Publicado: (2013) -
RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53(abnormal) myeloma cells independently of the p53 pathway
por: Surget, Sylvanie, et al.
Publicado: (2014) -
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
por: Tessoulin, Benoît, et al.
Publicado: (2018) -
Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups
por: Gomez-Bougie, Patricia, et al.
Publicado: (2014)